Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Cyanotech's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Cyanotech (CYAN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
16.68 %
Q2 2025
Net Margin
0.02 %
Q2 2025

Key Findings: Cyanotech vs Its Competitors

  • TTM: Trailing 12-month revenue of 25M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is holding steady (+1.9% annualized vs trailing 12 months).
  • Scale: Cyanotech ranks #19 of 37 companies by market capitalization in the Legal Cannabis industry, holding 0.0% of industry market cap.
  • Peer revenue share: Cyanotech accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CYAN Sales vs. its Competitors, Q2 2025

Cyanotech generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CYAN/competitors
https://api.csimarket.com/api/v1/companies/CYAN/relationships
https://api.csimarket.com/api/v1/companies/CYAN/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Legal Cannabis industry grew revenue 21.6% year over year, combined, vs 16.7% for Cyanotech. Cyanotech's share of combined industry revenue moved from 0.21% to 0.20%, a loss of 0.01 percentage points.

Cyanotech's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Cyanotech Corp No Yes Yes No
High-Confidence Competitors (1) - - - 0%
Similar-Size Competitors (10) 14% 38% 25% 70%
Similar Growth & Profitability (8) 12.50 % (1 of 8) 75.00 % (6 of 8) 62.50 % (5 of 8) 50.00 % (3 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2025

100%market share
  • Cyanotech100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Cyanotech and its 0 tracked competitors.

See Cyanotech's full market share breakdown »

CYAN Stock Performance relative to its Competitors

CYAN Competitors (weighted) Percent change over the selected range

Cyanotech's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
20%beat U.S.A. 500
Similar-Size
(1 of 5)
0%beat U.S.A. 500
Similar Growth & Profitability
(0 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Cyanotech Corp - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (5) 40.4% 63.2%
Similar Growth & Profitability (5) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Cyanotech's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

CYAN Stock Performance relative to High-Confidence Competitors

CYAN High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

CYAN Stock Performance relative to Similar-Size Competitors

CYAN Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

CYAN Stock Performance relative to Similar Growth & Profitability Competitors

CYAN Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Cyanotech's Comment on Competition and Industry Peers

The company produces Hawaiian Spirulina Pacifica products within the dietary supplement market, which includes vitamins, dietary supplements, algal products, and related nutritional items. Its competitors range from international to local producers and distributors, many possessing greater resources and a broader product range. Direct competition in the spirulina segment includes Parry Nutraceuticals, a division of the Murugappa Group of India, as well as several farms in China and numerous smaller farms globally. The company is among the largest spirulina producers and the sole producer based in Hawaii. It focuses on expanding market share among customers seeking high-quality products while adjusting its product mix to achieve revenue and profitability goals. Competitive advantages include trade secrets, proprietary know-how, customer relationships, climate, and geographic location. The company holds registered trademarks in the United States and select foreign markets, including the European Union.

Cyanotech's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Earthrise Named by the company 85% 2022 to 2026 3
Zivo Bioscience Inc Named by the company 85% 2022 to 2026 3
Nutrex Hawaii Named by the company 85% 2022 to 2026 3
Murugappa Group Named by the company 85% 2022 to 2026 3
Dainippon Ink and Chemical Company Named by the company 85% 2022 to 2026 3
Parry Nutraceuticals Named by the company 85% 2022 to 2026 3
Murugappa Group of India Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Cyanotech's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License